Taken all together, these findings suggest that the increased TNF-α and IL-1β, which may be caused by the activated microglia are related with negative symptoms of schizophrenia and anti-inflammatory may have therapeutic effects on clinical symptoms, especially on negative symptoms in schizophrenia. The gene discussed is IL1B; the disease is schizophrenia.